It is to transform lives for improved health and wellbeing through locally-driven solutions.
People to People Health Foundation (PPHF) works closely with communities and key actors on sustainable solutions for public health challenges. Our area of expertise include:
Chokolaate NEXT GEN, is Sri Lanka’s first online Education Exhibition, which enable you to visit and exhibition from the comfort of your home. Chokolaate is one of Sri Lanka’s leading youth Magazines who have been always in the forefront of bringing about new things for the generation of today, and the Next generation.
Perhaps one of the most important industries out of the affected is ‘Education’. No more Career fairs, Educational exhibitions, and no more ‘uni hunting’.
Taking in to consideration the difficulties faced by students, Sri Lanka’s most sought after youth magazine in another pioneering venture will host the countries first-ever virtual education exhibition, Next Gen. The online exhibition will be held on the 27th and 28th of March targeting students, parents and teachers. Next Gen will provide you with a platform to meet and draw your entire future career plan with a select group of universities.
Chokolaate has always considered Education a topmost priority and we are pleased to be able to take a step further and present NEXT GEN, Due to the COVID-19 outbreak, many events were halted, decisions concerning education were postponed and many were left indecisive when it came to future studies. Taking this into consideration and with an objective of providing a space for educationalists and potential students and parents to meet, Next Gen; was created.
It is now ‘that’ season where thousands of students are trying to map out their career paths or trying to decide what and where to study. The only problem is you can only do so much using the Internet. One only goes through this vital period of time once and Chokolaate have made it a mission to provide the maximum assistance to all students to take the best possible decision and make a strong and lasting foundation to their careers.
The exhibition will targets a majority of students from Advanced Level and Ordinary Level sections who are at a stage of decision making when it comes to their higher education. Students will have the ability to log into the exhibition website and visit the virtual stalls of the respective Universities where they will be able to interact one-on-one with University representatives, direct their concerns and questions, view university prospectus and other course details online and even browse scholarship opportunities.
Considering the importance of Rare Diseases for achieving health goal of India, PPHF facilitated a review process to understand the policy and program from leaders in the central and state government, experts, and industry along with review of secondary and published information. The purpose of the review was:
To analyze the available evidence and develop some priority action agenda for Rare Diseases in India. The key features of the process included:
Creating a supportive policy environment was one of the critical solutions that came up from the review process. Since then, PPHF has been actively working with its partners including international, national, and State players for organizing Regional and Global consultations to better understand critical drivers, strategies and solutions for Rare Diseases. To view the complete review document, please visit the resource section.
Both PPHF and FICCI collaboratively facilitated a review meeting for structured discussions around the draft rare disease policy released by the Government in the public domain for inputs. Over 40 diverse stakeholders, representing government, non-governmental organizations, civil society, corporate leaders, industry networks, bilateral development agencies, patient organizations, medical institutions, academia, researchers, clinicians and Rare Diseases experts, met for the Roundtable Discussion on “Draft National Policy for Rare Diseases” on February 7, 2020 using a structured participatory meeting methodology called Open Space Technology. The outcome of this discussion was a consensus document reflecting key recommendations to strengthen the Draft National Policy for Rare Diseases prepared from detailed deliberations by a diverse group of respected experts and stakeholders in Rare Diseases. The recommendations were submitted to the MoHFW, PMO and Finance Minister for further action. For detailed document, please visit the resource section.
PPHF and GRID Council, with support from Takeda Pharmaceuticals convened an international webinar on “Resilience approach towards rare disease policy in India” on 4th August 2020. The agenda for webinar was Resilience Approach Towards Rare Disease Policy in India highlighting the need to resurface and prioritize Rare Diseases as health priority in the COVID era. The webinar represented a combination of very high-level speakers from USA and India from sectors like Academia, industry, ministry, public health organizations, and patient advocates to help us better understand the opportunities and challenges for prioritization and management of Rare Diseases. For detailed report, please visit the resource section.
PPHF, jointly with the State Government of West Bengal, co-powered by Takeda Pharmaceutical, organized the virtual consultation on rare diseases for eastern states of India on 12th December 2020. The consultation was the first in the series - "The Blueprint for Rare Disease in India initiative", an attempt to enhance policy commitment to prioritize access, investment, and partnerships on rare diseases in India. Initiatives associate partners included ORDI, LSDSS, Cure SMA Foundation of India (Strategic partners), GRID council (Research partner) and Institute of Child Health, Kolkata (Knowledge partner). For the recommendations that came out from the event, please visit the resource section. And to view the event recording, click here. .
The second edition of the virtual conference, under the initiative “Blueprint of Rare Diseases in India” was held in collaboration with Government of Chandigarh and Punjab, for northern India on 22nd January 2021. The initiative is co-powered by Takeda Pharmaceutical and supported by Japan Embassy, Institute of Child Health, Kolkata, GRID Council, LSDSS, ORDI, RDIF, and Cure SMA Foundation of India. The recommendations from the consultation are to be released soon. To watch the event recording, click here.
The last regional event is scheduled for 16th February 2021 with the Government of Karnataka. The initiative is co-powered by Takeda Pharmaceutical and supported by Japan Embassy, Institute of Child Health, Kolkata, GRID Council, LSDSS, ORDI, RDIF, and Cure SMA Foundation of India. Click here to Register.
Recognizing the complexity of the issues around Rare Disease, we will bring a wide range of experts, champions, and leaders together from disciplines such as public health, industry body, NGOs, PAGs, IT, Media, COE, MOH&FW, Women and child development, Tribal Affairs, Ministry of State etc, NGOs and UN, bi-lateral and unilateral agencies, and others. The platform will highlight best practices across India and globally, learn from cross-country experience, and create sensitize stakeholders on prioritizing rare diseases. Following the conference, PPHF along with its partners will work towards compiling and submitting policy and programmatic concrete actions to the Government as part of supportive plan.